Showing results (1371-1380 of 1,397) with videos related to

Sort By:
Pageof 140
Infectious Diseases of Poverty|August 27, 2020
A five-compartment model of age-specific transmissibility of SARS-CoV-2Ze-Yu Zhao, Yuan-Zhao Zhu, Jing-Wen Xu, et al.
The Lancet. Infectious Diseases|July 20, 2023
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trialFeng-Cai Zhu, Guo-Hua Zhong, Wei-Jin Huang, et al.
The Lancet Regional Health. Western Pacific|June 7, 2023
Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trialZhao-Jun Mo, Shou-Jie Huang, Ling-Xian Qiu, et al.
ACS Medicinal Chemistry Letters|March 11, 2014
Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 ReceptorSatyamaheshwar Peddibhotla, Michael P Hedrick, Paul Hershberger, et al.
The Lancet. Infectious Diseases|April 13, 2024
Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trialHong-Xing Pan, Ling-Xian Qiu, Qi Liang, et al.
Cancer Medicine|January 12, 2020
Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysisWan-Lun Hsu, Yin-Chu Chien, Yen-Tsung Huang, et al.
Annals of Hematology|January 23, 2019
The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in TaiwanChien-Chang Lee, Hsiu-Hao Chang, Meng-Yao Lu, et al.
Nature Communications|April 19, 2025
An organ-wide spatiotemporal transcriptomic and cellular atlas of the regenerating zebrafish heartLei Li, Meina Lu, Lidong Guo, et al.
Science Bulletin|September 24, 2023
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trialYue-Mei Hu, Zhao-Feng Bi, Ya Zheng, et al.
Cancer Discovery|June 28, 2017
Immune Escape in Breast Cancer During <i>In Situ</i> to Invasive Carcinoma TransitionCarlos R Gil Del Alcazar, Sung Jin Huh, Muhammad B Ekram, et al.
Pageof 140